EUVIMEDEUVIMED entdecken
Crossref

systematic-review-of-population-pharmacokinetic-models-of-isoniazid-in-children-and-adults-with-tuberculosis

>Irfhan Ali Hyder Ali, >Sabariah Noor Harun, >Siti Maisharah Sheikh Ghadzi, >Wen Rui Tan

Malaysian Journal of Pharmacy · 2022

DOI: 10.52494/djiq7058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malaysian Journal of Pharmacy, 2022. Verfasst von >Irfhan Ali Hyder Ali und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Isoniazid (INH) is one of the first-line anti-tuberculosis (anti-TB) drugs that have both bactericidal and bacteriostatic properties depending on the rate of mycobacterial growth. Several population pharmacokinetic (PPK) models of INH were established. This systemic review aims to summarise published PPK parameters of INH in the models and to identify covariates influencing the INH pharmacokinetic parameters of models.

Method

A search of publications for PPK analyses of INH in volunteers or TB patients from 2011 to 2021 was conducted in PubMed and Scopus databases. Reviews, methodology articles, non-compartmental analysis, in vitro, and animal studies were excluded.

Result

Twelve studies were included in this review. Most of the included studies described the pharmacokinetics of INH as two-compartmental with first-order absorption and elimination in most of the included studies. Eleven studies reported N-acetyltransferase 2 (NAT2) genotype polymorphism as the most common significant covariate affecting the pharmacokinetic parameters of INH. Other common significant covariates reported include body weight (n = 2) and body mass index (BMI) (n = 1).

Conclusion

The variability of population clearance parameters of INH was explained mainly by the NAT2 genotype polymorphism. This indicates that to optimise and rationalise the dosing regimen of INH, a patient’s NAT2 genotype should be considered. At the same time, body weight and BMI values should be considered when making dosing adjustments for INH to achieve the therapeutic range.

Zitieren

APA

Ali, I. A. H., Harun, S. N., Ghadzi, S. M. S., & Tan, W. R. (2022). systematic-review-of-population-pharmacokinetic-models-of-isoniazid-in-children-and-adults-with-tuberculosis. Malaysian Journal of Pharmacy. https://doi.org/10.52494/djiq7058

Vancouver

Ali IAH, Harun SN, Ghadzi SMS, Tan WR. systematic-review-of-population-pharmacokinetic-models-of-isoniazid-in-children-and-adults-with-tuberculosis. Malaysian Journal of Pharmacy. 2022. doi:10.52494/djiq7058

BibTeX
@article{Ali2022,
  author = {Ali, >Irfhan Ali Hyder and Harun, >Sabariah Noor and Ghadzi, >Siti Maisharah Sheikh and Tan, >Wen Rui},
  title = {systematic-review-of-population-pharmacokinetic-models-of-isoniazid-in-children-and-adults-with-tuberculosis},
  journal = {Malaysian Journal of Pharmacy},
  year = {2022},
  doi = {10.52494/djiq7058}
}
Kostenlos starten →